Clinical Trials in Arizona

Showing 8421-8440 of 14,395 trials

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

NCT01649336

This is a Phase 1 study during which patients with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer will receive investigational study drug MEK162 and paclitaxel. Patients will receive increasing doses of study drug in combination with paclitaxel in order to achieve the highest dose of study drug possible that will not cause unacceptable side effects. Patients will be followed to see what side effects the combination causes and what effectiveness the combination has, if any, in treating the cancer. Approximately 36 patients from the US will be enrolled in this study.

Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer

Array Biopharma, now a wholly owned subsidiary of Pfizer36 participantsStarted Jul 2012

Scottsdale, Arizona, United States • Lafayette, Indiana, United States • New York, New York, United States +1 more locations

TERMINATEDPhase 231 miles

Renal AL Amyloid Involvement and NEOD001

NCT03168906

This is a multicenter, Phase 2b, randomized, double-blind, placebo-controlled, two-arm, parallel-group efficacy and safety study of NEOD001 as a single agent administered intravenously in adults with AL amyloidosis who have a maintained hematologic response to their most recent treatment for AL amyloidosis (e.g., chemotherapy, autologous stem cell transplant \[ASCT\]) and have persistent renal dysfunction.

Amyloidosis

Tufts Medical Center12 participantsStarted Jul 2017

Scottsdale, Arizona, United States • San Francisco, California, United States • Jacksonville, Florida, United States +6 more locations

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Renal AL Amyloid Involvement and NEOD001

Find Trials by Condition in Arizona

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation

A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

PROMINENT-Eye Ancillary Study (Protocol AD)

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Clinical Evaluation of Flortaucipir F 18

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

Behavioral Therapy Of Obstetric Sphincter Tears

An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

Dose Finding Study to Treat High Phosphate Levels in the Blood.

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation

A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Oral Iron for Erythropoietic Protoporphyrias